High expression levels of VEGF and MVD yielded poor prognosis results for patients after CRC surgery and indicated adverse effects on oncological clinical outcomes as demonstrated by the increased rates of vascular-lymphatic and lymph node metastasis and the increased incidence of distant metastases. The gene discussed is VEGFA; the disease is metastatic malignant neoplasm in the lymph nodes.